Shilpa Medicare (SHILPAMED) Share Price falls 2.33% to Rs 1,032; valuation stays rich
- September 30, 2026
- Posted by: Kunal Singla
- Category: News
Shilpa Medicare Share Price is trading at Rs 1,032, down 2.33% today, with a market capitalisation of Rs 20,011.93 crore. Shilpa Medicare Share Price has drawn attention because the move comes in a Large Cap healthcare name that is still priced well above the same-industry benchmark on earnings and book value. According to latest Univest figures, the stock is trading below its previous close and is lower on the latest session, while the opening range and day range show that the price moved between Rs 1,075 and Rs 1,032. Univest figures confirm the price action, but they do not point to a specific company trigger. This Shilpa Medicare Share Price update focuses on the verified price action, the valuation backdrop and the sector context that investors are watching on Univest.
Shilpa Medicare (SHILPAMED) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,032 |
| Previous Close | Rs 1,056.6 |
| Today's Move | -Rs 24.60 (-2.33%) |
| Open | Rs 1,049.75 |
| High | Rs 1,075 |
| Low | Rs 1,032 |
| Market Capitalisation | Rs 20,011.93 crore |
| Market Cap Category | Large Cap |
Shilpa Medicare Share Price started the trade at Rs 1,049.75, touched a high of Rs 1,075 and a low of Rs 1,032, and is last traded at Rs 1,032. The previous close was Rs 1,056.6, so the stock is down Rs 24.6, or 2.33%, in today’s decline. Shilpa Medicare Share Price is now near the day’s low, which makes the intraday move clear without requiring any inference beyond the numbers themselves. With a market capitalisation of Rs 20,011.93 crore, Shilpa Medicare Share Price sits in the Large Cap category for this company. For readers tracking Shilpa Medicare Share Price Today on Univest, the important point is that the decline is measurable, the range is defined and the stock remains a notable Healthcare counter.
From a market-news perspective, Shilpa Medicare Share Price is relevant because the move is large enough to register on the day’s decliner list, yet it still needs fundamental context before any conclusion can be drawn about valuation or positioning. That bridge matters for Shilpa Medicare Share Price analysis on Univest.
Shilpa Medicare (SHILPAMED) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 20,011.93 crore |
| P/E Ratio | 69.51x |
| P/B Ratio | 7.69x |
| ROE | 9.82% |
| ROCE | 11.43% |
| EPS | Rs 15.2 |
| Book Value Per Share | Rs 137.34 |
| Dividend Yield | 0.06% |
Shilpa Medicare (SHILPAMED) fundamental metrics show P/E 69.51x, P/B 7.69x, ROE 9.82%, ROCE 11.43%. Taken on their own, these numbers offer context rather than a trading signal.
Shilpa Medicare has a market capitalisation of Rs 20,011.93 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 69.51x, P/B at 7.69x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.82% and ROCE of 11.43%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 15.2, book value per share of Rs 137.34, dividend yield of 0.06%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.43x, median ROE of 11.7%, median ROCE of 13.61%. They set out the fundamental picture and are not a rating on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 69.51x |
| Benchmark Median P/E | 32.43x |
| Benchmark Average P/E | 49.46x |
| Benchmark P/E Range | 3.4x to 699.02x |
| Company P/B Ratio | 7.69x |
| Benchmark Median P/B | 2.89x |
| Benchmark Average P/B | 4.38x |
| Company ROE | 9.82% |
| Benchmark Median ROE | 11.7% |
| Benchmark Average ROE | 10.68% |
| Company ROCE | 11.43% |
| Benchmark Median ROCE | 13.61% |
| Benchmark Average ROCE | 13.4% |
| Company Market Capitalisation | Rs 20,011.93 crore |
| Benchmark Median Market Cap | Rs 776.09 crore |
| Benchmark Average Market Cap | Rs 14,255.4 crore |
Shilpa Medicare (SHILPAMED) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Shilpa Medicare (SHILPAMED) has a P/E ratio of 69.51x, which is above the benchmark median of 32.43x, a difference of +114.34%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Shilpa Medicare (SHILPAMED) has a ROE of 9.82%, which is below the benchmark median of 11.7%, a difference of -16.07%. Shilpa Medicare (SHILPAMED) has a ROCE of 11.43%, which is below the benchmark median of 13.61%, a difference of -16.02%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,41,477.63 | 36.9 | 5.16 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,53,031.38 | 85.99 | 14.24 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,85,216.32 | 85.72 | 20.83 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,20,897.46 | 26.42 | 4.42 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,12,205.15 | 33.15 | 3.18 | 11.83 | 16 |
Shilpa Medicare (SHILPAMED) has a P/E ratio of 69.51x compared with the displayed peer median of 36.9x. The comparison is relative and should not be read as a recommendation. Its ROE of 9.82% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 11.43% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Shilpa Medicare (SHILPAMED) has a market capitalisation of Rs 20,011.93 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Shilpa Medicare
- Shilpa Medicare Share Price fell 2.33% today, making the intraday move a live market focus on Univest.
- The stock trades at a P/E of 69.51 and P/B of 7.69, which keeps valuation central to Shilpa Medicare Share Price analysis.
- ROE of 9.82% and ROCE of 11.43% provide return-ratio context for the current Shilpa Medicare Share Price setup.
- The company sits in the Large Cap category with a market capitalisation of Rs 20,011.93 crore.
- Peer and sector comparisons show Shilpa Medicare Share Price above the industry median on valuation multiples.
About Shilpa Medicare
Shilpa Medicare operates in Healthcare, specifically the Pharmaceuticals & Drugs industry. The company’s business is assessed here through the financial metrics for Shilpa Medicare Share Price, including valuation, returns and balance-sheet-related per-share numbers. The stock is part of a broader pharma universe that includes large listed companies across branded formulations, specialty products and other drug-related businesses. For readers following Shilpa Medicare Stock News, the most useful verified context is that the company is a Large Cap healthcare name with a market value above Rs 20,000 crore and a valuation profile that stands out within its industry set.
Shilpa Medicare Share Price therefore reflects both company-specific valuation metrics and the wider pricing tone for Pharmaceuticals & Drugs on the market today.
Track Shilpa Medicare Share Price on Univest
Use Shilpa Medicare (SHILPAMED) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Shilpa Medicare Share Price can be tracked on Univest alongside live price updates, key ratios, 52-week levels and market insights. Readers can also follow Shilpa Medicare Share Price Today, Shilpa Medicare Fundamental Analysis and related Shilpa Medicare Stock News in one place. Univest keeps the company page useful for quick checks on valuation, return ratios and broader healthcare context without turning the discussion into a prediction.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Shilpa Medicare Share Price falling today?
Ans. Shilpa Medicare Share Price is down 2.33% today to Rs 1,032. Univest figures confirm the price action, but they do not point to a specific company trigger. The stock also sits below its previous close of Rs 1,056.6.
What is Shilpa Medicare Share Price today?
Ans. Shilpa Medicare Share Price is last traded at Rs 1,032. The session has ranged from Rs 1,032 to Rs 1,075, and the stock opened at Rs 1,049.75, which keeps the price action clearly defined for readers.
How much did Shilpa Medicare Share Price decline?
Ans. Shilpa Medicare Share Price declined by Rs 24.6, or 2.33%, versus the previous close. That move places the stock among the day’s weaker performers, though the article avoids any unsupported explanation beyond the verified figures.
What is Shilpa Medicare Share Price valuation?
Ans. Shilpa Medicare Share Price trades at a P/E of 69.51 and a P/B of 7.69. Both multiples are above the same-industry median and average, so valuation remains an important part of today’s stock analysis.
Is Shilpa Medicare Share Price expensive versus peers?
Ans. Relative to listed peers such as Sun Pharma, Cipla and Zydus Lifesciences, Shilpa Medicare Share Price looks rich on P/E and P/B. Its return ratios are also below several peer levels, which adds to the valuation comparison.
What do ROE and ROCE show for Shilpa Medicare Share Price?
Ans. Shilpa Medicare Share Price has ROE of 9.82% and ROCE of 11.43%. Both are positive, but they sit below the benchmark median and average for the same industry, which provides useful context for investors.
What is the market capitalisation of Shilpa Medicare Share Price?
Ans. Shilpa Medicare Share Price corresponds to a market capitalisation of Rs 20,011.93 crore. That places the company in the Large Cap category for this stock and gives context to its position in Healthcare.
How should investors read Shilpa Medicare Share Price news today?
Ans. Shilpa Medicare Share Price news today combines a 2.33% decline, a rich valuation profile and below-peer return ratios. The practical focus is on price action, sector comparison and verified financial metrics, not on forecasts or recommendations.
